Intellia Therapeutics (NASDAQ:NTLA) Earnings Information
Intellia Therapeutics last released its quarterly earnings results on November 5th, 2020. The reported ($0.47) earnings per share for the quarter, beating the consensus estimate of ($0.54) by $0.07. The firm had revenue of $22.22 million for the quarter, compared to analyst estimates of $14.95 million. Its revenue for the quarter was up 109.2% on a year-over-year basis. Intellia Therapeutics has generated ($2.11) earnings per share over the last year. Intellia Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 25th, 2021 based off prior year's report dates.
Intellia Therapeutics Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Intellia Therapeutics (NASDAQ:NTLA) Earnings Estimates
2021 EPS Consensus Estimate: ($2.88)
Intellia Therapeutics (NASDAQ NTLA) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)